Zeitschrift für Arzneimittelentwicklung
Offener Zugang

Abstrakt

Proposed Egyptian Protocol to Control of COVID-19

Tamer Ibrahim Abdel-Wahab, Sherif Ibrahim Abdel-Wahab, Eman Ibrahim Abdel-Wahab, Manal M. Adel

Drug discovery for anti-COVID-19 in humans to control COVID-19 infection in human blood and reduce the death rate by using EGYPTONA drug. This study assumes that a patient with COVID-19 should be treated medically by the proposed antiviral drug (EGYPTONA). Iron (Fe²⁺) – rich foods are the basic reasons for infection with COVID-19. The patient undergoes blood tests to know the level of Fe²⁺ in the blood, such as "serum ferritin" and "serum transferrin saturation" to check the degree of Fe²⁺ concentration. Clinical tests must be carried out for the proposed EGYPTONA drug to determine the appropriate concentration of its chemical ingredients since they can eliminate this virus and remove the symptoms resulting from it.